ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd. IMUC Peers
See (IMUC) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IMUC | $0.09 | -19.22% | 9.63M | 0.01 | $6.35 | N/A |
| NONOF | $66.00 | +1.32% | 292.99B | 19.24 | $3.43 | +2.52% |
| CSLLY | $75.69 | -1.32% | 146.60B | 27.83 | $2.72 | +1.76% |
| CMXHF | $151.25 | +2.55% | 73.24B | 27.75 | $5.45 | +1.83% |
| UCBJY | $88.21 | +1.73% | 34.81B | 28.45 | $3.10 | +0.61% |
| ARGNF | $562.00 | +2.00% | 34.32B | 44.04 | $12.76 | N/A |
| UCBJF | $174.55 | +0.48% | 33.17B | 28.20 | $6.19 | +0.70% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXIBF | $3.00 | N/A | 12.37B | 27.27 | $0.11 | N/A |
| GNMSF | $197.45 | +2.24% | 12.14B | 10.73 | $18.40 | N/A |
Stock Comparison
IMUC vs NONOF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, NONOF has a market cap of 292.99B. Regarding current trading prices, IMUC is priced at $0.09, while NONOF trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas NONOF's P/E ratio is 19.24. In terms of profitability, IMUC's ROE is +0.60%, compared to NONOF's ROE of +0.85%. Regarding short-term risk, IMUC is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CSLLY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CSLLY has a market cap of 146.60B. Regarding current trading prices, IMUC is priced at $0.09, while CSLLY trades at $75.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CSLLY's P/E ratio is 27.83. In terms of profitability, IMUC's ROE is +0.60%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, IMUC is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CMXHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CMXHF has a market cap of 73.24B. Regarding current trading prices, IMUC is priced at $0.09, while CMXHF trades at $151.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CMXHF's P/E ratio is 27.75. In terms of profitability, IMUC's ROE is +0.60%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, IMUC and CMXHF have similar daily volatility (0.00).
IMUC vs UCBJY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, UCBJY has a market cap of 34.81B. Regarding current trading prices, IMUC is priced at $0.09, while UCBJY trades at $88.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas UCBJY's P/E ratio is 28.45. In terms of profitability, IMUC's ROE is +0.60%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, IMUC is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ARGNF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, IMUC is priced at $0.09, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ARGNF's P/E ratio is 44.04. In terms of profitability, IMUC's ROE is +0.60%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, IMUC and ARGNF have similar daily volatility (0.00).
IMUC vs UCBJF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, UCBJF has a market cap of 33.17B. Regarding current trading prices, IMUC is priced at $0.09, while UCBJF trades at $174.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas UCBJF's P/E ratio is 28.20. In terms of profitability, IMUC's ROE is +0.60%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, IMUC and UCBJF have similar daily volatility (0.00).
IMUC vs ODTC Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, IMUC is priced at $0.09, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ODTC's P/E ratio is -0.08. In terms of profitability, IMUC's ROE is +0.60%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, IMUC and ODTC have similar daily volatility (0.00).
IMUC vs WXIBF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, WXIBF has a market cap of 12.37B. Regarding current trading prices, IMUC is priced at $0.09, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, IMUC's ROE is +0.60%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, IMUC and WXIBF have similar daily volatility (0.00).
IMUC vs GNMSF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, GNMSF has a market cap of 12.14B. Regarding current trading prices, IMUC is priced at $0.09, while GNMSF trades at $197.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas GNMSF's P/E ratio is 10.73. In terms of profitability, IMUC's ROE is +0.60%, compared to GNMSF's ROE of +0.24%. Regarding short-term risk, IMUC is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs WXXWY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, WXXWY has a market cap of 12.07B. Regarding current trading prices, IMUC is priced at $0.09, while WXXWY trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas WXXWY's P/E ratio is 28.26. In terms of profitability, IMUC's ROE is +0.60%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, IMUC is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs IVBXF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, IVBXF has a market cap of 11.26B. Regarding current trading prices, IMUC is priced at $0.09, while IVBXF trades at $6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas IVBXF's P/E ratio is -687.50. In terms of profitability, IMUC's ROE is +0.60%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, IMUC is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs SBMFF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SBMFF has a market cap of 8.81B. Regarding current trading prices, IMUC is priced at $0.09, while SBMFF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SBMFF's P/E ratio is 49.25. In terms of profitability, IMUC's ROE is +0.60%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, IMUC and SBMFF have similar daily volatility (0.00).
IMUC vs SBHMY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, IMUC is priced at $0.09, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, IMUC's ROE is +0.60%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, IMUC is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs TLPPF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, TLPPF has a market cap of 5.68B. Regarding current trading prices, IMUC is priced at $0.09, while TLPPF trades at $16.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas TLPPF's P/E ratio is 186.78. In terms of profitability, IMUC's ROE is +0.60%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, IMUC is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ABCZF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, IMUC is priced at $0.09, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, IMUC's ROE is +0.60%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, IMUC and ABCZF have similar daily volatility (0.00).
IMUC vs INCPF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, IMUC is priced at $0.09, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas INCPF's P/E ratio is -108.67. In terms of profitability, IMUC's ROE is +0.60%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, IMUC and INCPF have similar daily volatility (0.00).
IMUC vs AKBLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, IMUC is priced at $0.09, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas AKBLF's P/E ratio is 38.13. In terms of profitability, IMUC's ROE is +0.60%, compared to AKBLF's ROE of +0.16%. Regarding short-term risk, IMUC is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs LABFF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, IMUC is priced at $0.09, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas LABFF's P/E ratio is 28.95. In terms of profitability, IMUC's ROE is +0.60%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, IMUC and LABFF have similar daily volatility (0.00).
IMUC vs ZLDPF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ZLDPF has a market cap of 4.47B. Regarding current trading prices, IMUC is priced at $0.09, while ZLDPF trades at $63.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ZLDPF's P/E ratio is -25.72. In terms of profitability, IMUC's ROE is +0.60%, compared to ZLDPF's ROE of -0.15%. Regarding short-term risk, IMUC is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CAMRF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CAMRF has a market cap of 3.82B. Regarding current trading prices, IMUC is priced at $0.09, while CAMRF trades at $65.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CAMRF's P/E ratio is 88.04. In terms of profitability, IMUC's ROE is +0.60%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, IMUC is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs SHJBF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, IMUC is priced at $0.09, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, IMUC's ROE is +0.60%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, IMUC and SHJBF have similar daily volatility (0.00).
IMUC vs REGMF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, REGMF has a market cap of 3.25B. Regarding current trading prices, IMUC is priced at $0.09, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas REGMF's P/E ratio is -13.32. In terms of profitability, IMUC's ROE is +0.60%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, IMUC is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs GNNSF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, IMUC is priced at $0.09, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, IMUC's ROE is +0.60%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, IMUC and GNNSF have similar daily volatility (0.00).
IMUC vs TKBIF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, IMUC is priced at $0.09, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, IMUC's ROE is +0.60%, compared to TKBIF's ROE of N/A. Regarding short-term risk, IMUC and TKBIF have similar daily volatility (0.00).
IMUC vs MPSYF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, IMUC is priced at $0.09, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, IMUC's ROE is +0.60%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, IMUC is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ASPHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, IMUC is priced at $0.09, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, IMUC's ROE is +0.60%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, IMUC and ASPHF have similar daily volatility (0.00).
IMUC vs BVNKF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, IMUC is priced at $0.09, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BVNKF's P/E ratio is 14.03. In terms of profitability, IMUC's ROE is +0.60%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, IMUC is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs TRSBF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, TRSBF has a market cap of 1.95B. Regarding current trading prices, IMUC is priced at $0.09, while TRSBF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas TRSBF's P/E ratio is 9.20. In terms of profitability, IMUC's ROE is +0.60%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, IMUC and TRSBF have similar daily volatility (0.00).
IMUC vs BVNRY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BVNRY has a market cap of 1.93B. Regarding current trading prices, IMUC is priced at $0.09, while BVNRY trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BVNRY's P/E ratio is 12.88. In terms of profitability, IMUC's ROE is +0.60%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, IMUC and BVNRY have similar daily volatility (0.00).
IMUC vs BTTAY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, IMUC is priced at $0.09, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BTTAY's P/E ratio is 65.49. In terms of profitability, IMUC's ROE is +0.60%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, IMUC is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs MEOBF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, IMUC is priced at $0.09, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, IMUC's ROE is +0.60%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, IMUC is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs GENSF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, GENSF has a market cap of 1.79B. Regarding current trading prices, IMUC is priced at $0.09, while GENSF trades at $27.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas GENSF's P/E ratio is -340.95. In terms of profitability, IMUC's ROE is +0.60%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, IMUC is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PPTDF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, IMUC is priced at $0.09, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PPTDF's P/E ratio is 16.70. In terms of profitability, IMUC's ROE is +0.60%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, IMUC is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ONTTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ONTTF has a market cap of 1.74B. Regarding current trading prices, IMUC is priced at $0.09, while ONTTF trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ONTTF's P/E ratio is -8.62. In terms of profitability, IMUC's ROE is +0.60%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, IMUC is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs BIESF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BIESF has a market cap of 1.61B. Regarding current trading prices, IMUC is priced at $0.09, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BIESF's P/E ratio is 42.67. In terms of profitability, IMUC's ROE is +0.60%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, IMUC and BIESF have similar daily volatility (0.00).
IMUC vs BRCTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BRCTF has a market cap of 1.59B. Regarding current trading prices, IMUC is priced at $0.09, while BRCTF trades at $17.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BRCTF's P/E ratio is -85.61. In terms of profitability, IMUC's ROE is +0.60%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, IMUC is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs GLPGF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, GLPGF has a market cap of 1.48B. Regarding current trading prices, IMUC is priced at $0.09, while GLPGF trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas GLPGF's P/E ratio is -7.25. In terms of profitability, IMUC's ROE is +0.60%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, IMUC is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PHMMF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, IMUC is priced at $0.09, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PHMMF's P/E ratio is 63.21. In terms of profitability, IMUC's ROE is +0.60%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, IMUC and PHMMF have similar daily volatility (0.00).
IMUC vs CSBTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CSBTF has a market cap of 1.05B. Regarding current trading prices, IMUC is priced at $0.09, while CSBTF trades at $27.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CSBTF's P/E ratio is -228.92. In terms of profitability, IMUC's ROE is +0.60%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, IMUC is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs NURPF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, IMUC is priced at $0.09, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas NURPF's P/E ratio is 11.63. In terms of profitability, IMUC's ROE is +0.60%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, IMUC is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ASCLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, IMUC is priced at $0.09, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, IMUC's ROE is +0.60%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, IMUC is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CSPHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, IMUC is priced at $0.09, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, IMUC's ROE is +0.60%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, IMUC is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PHGUF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PHGUF has a market cap of 621.12M. Regarding current trading prices, IMUC is priced at $0.09, while PHGUF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PHGUF's P/E ratio is -45.65. In terms of profitability, IMUC's ROE is +0.60%, compared to PHGUF's ROE of -0.05%. Regarding short-term risk, IMUC is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs BPMUF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, IMUC is priced at $0.09, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BPMUF's P/E ratio is 6.70. In terms of profitability, IMUC's ROE is +0.60%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, IMUC is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs INRLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, IMUC is priced at $0.09, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas INRLF's P/E ratio is -36.11. In terms of profitability, IMUC's ROE is +0.60%, compared to INRLF's ROE of -0.06%. Regarding short-term risk, IMUC and INRLF have similar daily volatility (0.00).
IMUC vs SOLTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, IMUC is priced at $0.09, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, IMUC's ROE is +0.60%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, IMUC is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CLTEF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, IMUC is priced at $0.09, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, IMUC's ROE is +0.60%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, IMUC and CLTEF have similar daily volatility (0.00).
IMUC vs VBIZF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, IMUC is priced at $0.09, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, IMUC's ROE is +0.60%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, IMUC and VBIZF have similar daily volatility (0.00).
IMUC vs CYDY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CYDY has a market cap of 472.02M. Regarding current trading prices, IMUC is priced at $0.09, while CYDY trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CYDY's P/E ratio is -19.15. In terms of profitability, IMUC's ROE is +0.60%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, IMUC is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs SNBIF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, IMUC is priced at $0.09, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, IMUC's ROE is +0.60%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, IMUC is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CKDXF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CKDXF has a market cap of 471.30M. Regarding current trading prices, IMUC is priced at $0.09, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, IMUC's ROE is +0.60%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, IMUC is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs AAVXF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, AAVXF has a market cap of 457.25M. Regarding current trading prices, IMUC is priced at $0.09, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas AAVXF's P/E ratio is -2.27. In terms of profitability, IMUC's ROE is +0.60%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, IMUC and AAVXF have similar daily volatility (0.00).
IMUC vs BXPHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BXPHF has a market cap of 449.41M. Regarding current trading prices, IMUC is priced at $0.09, while BXPHF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BXPHF's P/E ratio is -23.00. In terms of profitability, IMUC's ROE is +0.60%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, IMUC and BXPHF have similar daily volatility (0.00).
IMUC vs TBGNF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, IMUC is priced at $0.09, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, IMUC's ROE is +0.60%, compared to TBGNF's ROE of N/A. Regarding short-term risk, IMUC and TBGNF have similar daily volatility (0.00).
IMUC vs HBMHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, HBMHF has a market cap of 407.50M. Regarding current trading prices, IMUC is priced at $0.09, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, IMUC's ROE is +0.60%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, IMUC and HBMHF have similar daily volatility (0.00).
IMUC vs PTCHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PTCHF has a market cap of 396.31M. Regarding current trading prices, IMUC is priced at $0.09, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, IMUC's ROE is +0.60%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, IMUC and PTCHF have similar daily volatility (0.00).
IMUC vs NWBO Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, NWBO has a market cap of 394.69M. Regarding current trading prices, IMUC is priced at $0.09, while NWBO trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas NWBO's P/E ratio is -4.05. In terms of profitability, IMUC's ROE is +0.60%, compared to NWBO's ROE of +1.24%. Regarding short-term risk, IMUC is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CLVLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CLVLF has a market cap of 379.94M. Regarding current trading prices, IMUC is priced at $0.09, while CLVLF trades at $7.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CLVLF's P/E ratio is 15.47. In terms of profitability, IMUC's ROE is +0.60%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, IMUC and CLVLF have similar daily volatility (0.00).
IMUC vs CLVLY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CLVLY has a market cap of 358.38M. Regarding current trading prices, IMUC is priced at $0.09, while CLVLY trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CLVLY's P/E ratio is 14.30. In terms of profitability, IMUC's ROE is +0.60%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, IMUC is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs IVEVF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, IVEVF has a market cap of 347.57M. Regarding current trading prices, IMUC is priced at $0.09, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas IVEVF's P/E ratio is -1.04. In terms of profitability, IMUC's ROE is +0.60%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, IMUC and IVEVF have similar daily volatility (0.00).
IMUC vs IDRSF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, IDRSF has a market cap of 337.12M. Regarding current trading prices, IMUC is priced at $0.09, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas IDRSF's P/E ratio is -0.85. In terms of profitability, IMUC's ROE is +0.60%, compared to IDRSF's ROE of +0.29%. Regarding short-term risk, IMUC is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PRRUF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, IMUC is priced at $0.09, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, IMUC's ROE is +0.60%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, IMUC is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs BOVNF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, IMUC is priced at $0.09, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, IMUC's ROE is +0.60%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, IMUC and BOVNF have similar daily volatility (0.00).
IMUC vs PBBIF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, IMUC is priced at $0.09, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, IMUC's ROE is +0.60%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, IMUC is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs BSEM Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BSEM has a market cap of 247.53M. Regarding current trading prices, IMUC is priced at $0.09, while BSEM trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BSEM's P/E ratio is -26.58. In terms of profitability, IMUC's ROE is +0.60%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, IMUC is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ORYZF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, IMUC is priced at $0.09, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, IMUC's ROE is +0.60%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, IMUC and ORYZF have similar daily volatility (0.00).
IMUC vs NWPHF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, IMUC is priced at $0.09, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas NWPHF's P/E ratio is N/A. In terms of profitability, IMUC's ROE is +0.60%, compared to NWPHF's ROE of N/A. Regarding short-term risk, IMUC and NWPHF have similar daily volatility (0.00).
IMUC vs MDCLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, IMUC is priced at $0.09, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, IMUC's ROE is +0.60%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, IMUC is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs HLOSF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, IMUC is priced at $0.09, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas HLOSF's P/E ratio is -6.82. In terms of profitability, IMUC's ROE is +0.60%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, IMUC is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs SPHDF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, IMUC is priced at $0.09, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SPHDF's P/E ratio is -3.91. In terms of profitability, IMUC's ROE is +0.60%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, IMUC is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs RAONF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, IMUC is priced at $0.09, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas RAONF's P/E ratio is -20.33. In terms of profitability, IMUC's ROE is +0.60%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, IMUC is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs FPHAF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, IMUC is priced at $0.09, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, IMUC's ROE is +0.60%, compared to FPHAF's ROE of N/A. Regarding short-term risk, IMUC and FPHAF have similar daily volatility (0.00).
IMUC vs VSBC Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, IMUC is priced at $0.09, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas VSBC's P/E ratio is N/A. In terms of profitability, IMUC's ROE is +0.60%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, IMUC and VSBC have similar daily volatility (0.00).
IMUC vs FGHQF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, IMUC is priced at $0.09, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, IMUC's ROE is +0.60%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, IMUC is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs HNSBF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, IMUC is priced at $0.09, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, IMUC's ROE is +0.60%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, IMUC is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs AVCTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, AVCTF has a market cap of 199.39M. Regarding current trading prices, IMUC is priced at $0.09, while AVCTF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas AVCTF's P/E ratio is -4.33. In terms of profitability, IMUC's ROE is +0.60%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, IMUC is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs NGENF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, NGENF has a market cap of 180.93M. Regarding current trading prices, IMUC is priced at $0.09, while NGENF trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas NGENF's P/E ratio is -9.77. In terms of profitability, IMUC's ROE is +0.60%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, IMUC is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs GNFTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, IMUC is priced at $0.09, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, IMUC's ROE is +0.60%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, IMUC is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs SCNLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, IMUC is priced at $0.09, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, IMUC's ROE is +0.60%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, IMUC and SCNLF have similar daily volatility (0.00).
IMUC vs OPORF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, IMUC is priced at $0.09, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas OPORF's P/E ratio is 12.00. In terms of profitability, IMUC's ROE is +0.60%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, IMUC is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs IUGNF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, IUGNF has a market cap of 156.81M. Regarding current trading prices, IMUC is priced at $0.09, while IUGNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas IUGNF's P/E ratio is -2.10. In terms of profitability, IMUC's ROE is +0.60%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, IMUC and IUGNF have similar daily volatility (0.00).
IMUC vs MLLCF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, IMUC is priced at $0.09, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas MLLCF's P/E ratio is -2.19. In terms of profitability, IMUC's ROE is +0.60%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, IMUC is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs RECEF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, IMUC is priced at $0.09, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas RECEF's P/E ratio is -10.00. In terms of profitability, IMUC's ROE is +0.60%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, IMUC is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs BRIBF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, BRIBF has a market cap of 134.08M. Regarding current trading prices, IMUC is priced at $0.09, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, IMUC's ROE is +0.60%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, IMUC and BRIBF have similar daily volatility (0.00).
IMUC vs IPHYF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, IMUC is priced at $0.09, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, IMUC's ROE is +0.60%, compared to IPHYF's ROE of -0.84%. Regarding short-term risk, IMUC is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs AAPGV Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, IMUC is priced at $0.09, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas AAPGV's P/E ratio is N/A. In terms of profitability, IMUC's ROE is +0.60%, compared to AAPGV's ROE of N/A. Regarding short-term risk, IMUC is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PRNAF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, IMUC is priced at $0.09, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, IMUC's ROE is +0.60%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, IMUC and PRNAF have similar daily volatility (0.00).
IMUC vs AMGXF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, IMUC is priced at $0.09, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, IMUC's ROE is +0.60%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, IMUC is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PSTTF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, IMUC is priced at $0.09, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, IMUC's ROE is +0.60%, compared to PSTTF's ROE of N/A. Regarding short-term risk, IMUC and PSTTF have similar daily volatility (0.00).
IMUC vs EPRXF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, IMUC is priced at $0.09, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, IMUC's ROE is +0.60%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, IMUC is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ADOIF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, IMUC is priced at $0.09, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, IMUC's ROE is +0.60%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, IMUC and ADOIF have similar daily volatility (0.00).
IMUC vs TRGNF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, IMUC is priced at $0.09, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, IMUC's ROE is +0.60%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, IMUC is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs CMVLF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, IMUC is priced at $0.09, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, IMUC's ROE is +0.60%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, IMUC is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ADOCY Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ADOCY has a market cap of 87.11M. Regarding current trading prices, IMUC is priced at $0.09, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, IMUC's ROE is +0.60%, compared to ADOCY's ROE of +1.28%. Regarding short-term risk, IMUC and ADOCY have similar daily volatility (0.00).
IMUC vs MCURF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, IMUC is priced at $0.09, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas MCURF's P/E ratio is -16.90. In terms of profitability, IMUC's ROE is +0.60%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, IMUC is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs PBIGF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, PBIGF has a market cap of 83.73M. Regarding current trading prices, IMUC is priced at $0.09, while PBIGF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas PBIGF's P/E ratio is -7.17. In terms of profitability, IMUC's ROE is +0.60%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, IMUC is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs ACHFF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ACHFF has a market cap of 79.17M. Regarding current trading prices, IMUC is priced at $0.09, while ACHFF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ACHFF's P/E ratio is -30.16. In terms of profitability, IMUC's ROE is +0.60%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, IMUC is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for IMUC.
IMUC vs KNTPF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, IMUC is priced at $0.09, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, IMUC's ROE is +0.60%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, IMUC and KNTPF have similar daily volatility (0.00).
IMUC vs ETXPF Comparison
IMUC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMUC stands at 9.63M. In comparison, ETXPF has a market cap of 75.96M. Regarding current trading prices, IMUC is priced at $0.09, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMUC currently has a P/E ratio of 0.01, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, IMUC's ROE is +0.60%, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, IMUC and ETXPF have similar daily volatility (0.00).